BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Depomed, Inc. 

1360 O'Brien Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-462-5900 Fax: 650-462-9993


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Delivery





 Company News
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014 7:44:38 AM    More...
Depomed, Inc. (DEPO) Reports Fourth Quarter And Full Year 2013 Financial Result 3/13/2014 6:04:46 AM    More...
Depomed, Inc. (DEPO) To Report Fourth Quarter Fiscal Year 2013 Financial Results On Wednesday, March 12, 2014 3/11/2014 6:08:13 AM    More...
Depomed, Inc. (DEPO) To Present At The 26th Annual ROTH Conference On Monday, March 10, 2014 3/6/2014 6:17:32 AM    More...
Depomed, Inc. (DEPO) Reports Preliminary Q4 2013 And Full Year Financial Information 2/26/2014 6:14:16 AM    More...
Depomed, Inc. (DEPO) To Present At Upcoming Healthcare Conferences 2/21/2014 6:13:54 AM    More...
Depomed, Inc. (DEPO) Announces Favorable Markman Ruling In GRALISE® Patent Litigation 1/29/2014 11:59:43 AM    More...
Depomed, Inc. (DEPO) BagsCAMBIA® Migraine Med From Nautilus Neurosciences, Inc. For $48.7 Million 12/18/2013 6:58:02 AM    More...
Depomed, Inc. (DEPO) To Present At Piper Jaffray 2013 Healthcare Conference 12/2/2013 6:57:13 AM    More...
Depomed, Inc. (DEPO) Reports Third Quarter 2013 Financial Results 11/6/2013 7:41:52 AM    More...
12345678910...